Alpha Tau Medical Ltd. SEC filings DRTS

Alpha Tau Medical Ltd. has 239 filings in SEC EDGAR's recent list, going back to Jul 8, 2021. Its latest annual report, Form 20-F, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.

Alpha Tau Medical Ltd. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 29, 2026 Oct 29, 2026
6-K Current report (foreign issuer) Oct 22, 2026 Oct 22, 2026
6-K Current report (foreign issuer) Oct 19, 2026 Oct 19, 2026
6-K Current report (foreign issuer) Aug 31, 2026 Aug 31, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 12, 2026 Aug 11, 2026
6-K Current report (foreign issuer) Aug 10, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 10, 2026 Aug 10, 2026
6-K Current report (foreign issuer) Jul 21, 2026 Jul 21, 2026
6-K Current report (foreign issuer) Jul 15, 2026 Jul 15, 2026
4 Insider transaction Jul 7, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 6, 2026 Jul 2, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 2, 2026 —
4 Insider transaction Jul 1, 2026 Jun 30, 2026
144 Notice of proposed sale Jun 30, 2026 —
4 Insider transaction Jun 26, 2026 Jun 25, 2026
144 Notice of proposed sale Jun 26, 2026 —
6-K Current report (foreign issuer) Jun 25, 2026 Jun 25, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
6-K Current report (foreign issuer) Jun 23, 2026 Jun 23, 2026
144 Notice of proposed sale Jun 23, 2026 —
6-K Current report (foreign issuer) Jun 11, 2026 Jun 11, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
144 Notice of proposed sale Jun 4, 2026 —
6-K Current report (foreign issuer) Jun 3, 2026 Jun 3, 2026
6-K Current report (foreign issuer) Jun 1, 2026 Jun 1, 2026
6-K Current report (foreign issuer) May 18, 2026 May 18, 2026
6-K Current report (foreign issuer) May 18, 2026 May 18, 2026
6-K Current report (foreign issuer) May 11, 2026 May 11, 2026
6-K Current report (foreign issuer) May 11, 2026 May 11, 2026
6-K Current report (foreign issuer) May 8, 2026 May 8, 2026
6-K Current report (foreign issuer) May 8, 2026 May 8, 2026
6-K Current report (foreign issuer) May 7, 2026 May 7, 2026
6-K Current report (foreign issuer) May 5, 2026 May 5, 2026
6-K Current report (foreign issuer) May 4, 2026 May 4, 2026
EFFECT Filing May 1, 2026 —
CORRESP Letter to the SEC Apr 30, 2026 —
UPLOAD Letter from the SEC Apr 30, 2026 —
F-3 Shelf registration (foreign issuer) Apr 28, 2026 —
6-K Current report (foreign issuer) Apr 27, 2026 Apr 27, 2026
6-K Current report (foreign issuer) Apr 23, 2026 Apr 23, 2026
6-K Current report (foreign issuer) Mar 31, 2026 Mar 31, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
S-8 Employee stock plan registration Mar 9, 2026 —
6-K Current report (foreign issuer) Mar 9, 2026 Mar 9, 2026
20-F Annual report (foreign issuer) Mar 9, 2026 Dec 31, 2025
144 Notice of proposed sale Feb 26, 2026 —
6-K Current report (foreign issuer) Feb 24, 2026 Feb 24, 2026
144 Notice of proposed sale Feb 2, 2026 —
6-K Current report (foreign issuer) Jan 29, 2026 Jan 29, 2026
144 Notice of proposed sale Jan 14, 2026 —
144 Notice of proposed sale Jan 12, 2026 —
144 Notice of proposed sale Jan 9, 2026 —
144 Notice of proposed sale Jan 9, 2026 —
6-K Current report (foreign issuer) Jan 6, 2026 Jan 6, 2026
6-K Current report (foreign issuer) Jan 5, 2026 Jan 5, 2026
6-K Current report (foreign issuer) Dec 18, 2025 Dec 18, 2025
144 Notice of proposed sale Dec 11, 2025 —
6-K Current report (foreign issuer) Dec 9, 2025 Dec 9, 2025
6-K Current report (foreign issuer) Dec 4, 2025 Dec 4, 2025
6-K Current report (foreign issuer) Dec 2, 2025 Dec 2, 2025
144 Notice of proposed sale Dec 1, 2025 —
6-K Current report (foreign issuer) Nov 20, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 3, 2025 —
6-K Current report (foreign issuer) Oct 21, 2025 Oct 21, 2025
144 Notice of proposed sale Oct 1, 2025 —
6-K Current report (foreign issuer) Sep 2, 2025 Sep 2, 2025
6-K Current report (foreign issuer) Aug 27, 2025 Aug 27, 2025
6-K Current report (foreign issuer) Aug 11, 2025 Jun 30, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 24, 2025 —
EFFECT Filing Jul 2, 2025 —
CORRESP Letter to the SEC Jun 30, 2025 —
UPLOAD Letter from the SEC Jun 27, 2025 —
F-3 Shelf registration (foreign issuer) Jun 23, 2025 —
6-K Current report (foreign issuer) Jun 17, 2025 Jun 17, 2025
6-K Current report (foreign issuer) May 28, 2025 May 28, 2025
6-K Current report (foreign issuer) May 19, 2025 May 19, 2025
6-K Current report (foreign issuer) May 13, 2025 May 13, 2025
6-K Current report (foreign issuer) May 12, 2025 May 12, 2025
6-K Current report (foreign issuer) May 6, 2025 May 6, 2025
SCHEDULE 13D Ownership over 5% (active) May 1, 2025 —
6-K Current report (foreign issuer) Apr 28, 2025 Apr 28, 2025
424B5 Prospectus supplement Apr 28, 2025 —
6-K Current report (foreign issuer) Apr 2, 2025 Apr 2, 2025
S-8 Employee stock plan registration Mar 12, 2025 —
6-K Current report (foreign issuer) Mar 12, 2025 Mar 12, 2025
20-F Annual report (foreign issuer) Mar 12, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Feb 27, 2025 Feb 27, 2025
6-K Current report (foreign issuer) Feb 24, 2025 Feb 24, 2025
6-K Current report (foreign issuer) Feb 3, 2025 Feb 3, 2025
6-K Current report (foreign issuer) Jan 27, 2025 Jan 27, 2025
6-K Current report (foreign issuer) Dec 18, 2024 Dec 18, 2024
6-K Current report (foreign issuer) Dec 17, 2024 Dec 17, 2024
6-K Current report (foreign issuer) Dec 17, 2024 Dec 17, 2024
6-K Current report (foreign issuer) Dec 11, 2024 Dec 11, 2024
6-K Current report (foreign issuer) Dec 6, 2024 Dec 6, 2024
6-K Current report (foreign issuer) Nov 19, 2024 Nov 19, 2024
6-K Current report (foreign issuer) Nov 13, 2024 Nov 13, 2024
6-K Current report (foreign issuer) Nov 12, 2024 Nov 12, 2024
6-K Current report (foreign issuer) Oct 21, 2024 Oct 21, 2024
6-K Current report (foreign issuer) Oct 10, 2024 Oct 10, 2024
6-K Current report (foreign issuer) Sep 20, 2024 Sep 20, 2024
6-K Current report (foreign issuer) Aug 22, 2024 Aug 22, 2024
6-K Current report (foreign issuer) Aug 14, 2024 Aug 14, 2024
6-K Current report (foreign issuer) Aug 14, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Jun 25, 2024 Jun 25, 2024
6-K Current report (foreign issuer) May 21, 2024 May 21, 2024
6-K Current report (foreign issuer) May 20, 2024 May 20, 2024
6-K Current report (foreign issuer) May 13, 2024 May 13, 2024
6-K Current report (foreign issuer) May 6, 2024 May 6, 2024
6-K Current report (foreign issuer) May 1, 2024 May 1, 2024
6-K Current report (foreign issuer) Mar 25, 2024 Mar 25, 2024
144 Notice of proposed sale Mar 15, 2024 —
S-8 Employee stock plan registration Mar 7, 2024 —
6-K Current report (foreign issuer) Mar 7, 2024 Mar 7, 2024
20-F Annual report (foreign issuer) Mar 7, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Feb 26, 2024 Feb 26, 2024
6-K Current report (foreign issuer) Dec 20, 2023 Dec 20, 2023
144 Notice of proposed sale Dec 18, 2023 —
6-K Current report (foreign issuer) Nov 29, 2023 Nov 29, 2023
6-K Current report (foreign issuer) Nov 28, 2023 Nov 28, 2023
6-K Current report (foreign issuer) Nov 20, 2023 Nov 20, 2023
6-K Current report (foreign issuer) Nov 16, 2023 Nov 16, 2023
6-K Current report (foreign issuer) Nov 1, 2023 Nov 1, 2023
6-K Current report (foreign issuer) Nov 1, 2023 Nov 1, 2023
6-K Current report (foreign issuer) Oct 30, 2023 Oct 30, 2023
6-K Current report (foreign issuer) Oct 24, 2023 Oct 24, 2023
6-K Current report (foreign issuer) Sep 27, 2023 Sep 27, 2023
EFFECT Filing Sep 22, 2023 —
CORRESP Letter to the SEC Sep 20, 2023 —
UPLOAD Letter from the SEC Sep 19, 2023 —
6-K Current report (foreign issuer) Sep 14, 2023 Sep 14, 2023
F-3 Shelf registration (foreign issuer) Sep 11, 2023 —
6-K Current report (foreign issuer) Aug 28, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Aug 28, 2023 Aug 28, 2023
6-K Current report (foreign issuer) Aug 24, 2023 Aug 24, 2023
6-K Current report (foreign issuer) Aug 17, 2023 Aug 17, 2023
6-K Current report (foreign issuer) Aug 2, 2023 Aug 2, 2023
144 Notice of proposed sale Jun 9, 2023 —
144 Notice of proposed sale Jun 8, 2023 —
144 Notice of proposed sale Jun 8, 2023 —
144 Notice of proposed sale Jun 6, 2023 —
6-K Current report (foreign issuer) Jun 6, 2023 Jun 6, 2023
144 Notice of proposed sale Jun 2, 2023 —
6-K Current report (foreign issuer) May 24, 2023 May 24, 2023
6-K Current report (foreign issuer) May 23, 2023 May 23, 2023
6-K Current report (foreign issuer) May 3, 2023 May 3, 2023
EFFECT Filing Apr 13, 2023 —
424B3 Prospectus Apr 13, 2023 —
EFFECT Filing Apr 11, 2023 —
CORRESP Letter to the SEC Apr 11, 2023 —
UPLOAD Letter from the SEC Apr 10, 2023 —
6-K Current report (foreign issuer) Apr 3, 2023 Apr 3, 2023
POS AM Post-effective amendment no. 2 to form f-1 Apr 3, 2023 —
F-3 Shelf registration (foreign issuer) Apr 3, 2023 —
6-K Current report (foreign issuer) Mar 29, 2023 Mar 29, 2023
20-F/A Amended annual report (foreign issuer) Mar 23, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Mar 13, 2023 Mar 13, 2023
S-8 Employee stock plan registration Mar 9, 2023 —
424B3 Prospectus Mar 9, 2023 —
6-K Current report (foreign issuer) Mar 9, 2023 Mar 9, 2023
20-F Annual report (foreign issuer) Mar 9, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Mar 8, 2023 Mar 8, 2023
6-K Current report (foreign issuer) Mar 3, 2023 Mar 3, 2023
6-K Current report (foreign issuer) Mar 1, 2023 Mar 1, 2023
6-K Current report (foreign issuer) Feb 21, 2023 Feb 21, 2023
6-K Current report (foreign issuer) Dec 13, 2022 Dec 13, 2022
424B3 Prospectus Nov 22, 2022 —
6-K Current report (foreign issuer) Nov 22, 2022 Nov 22, 2022
6-K Current report (foreign issuer) Nov 10, 2022 Nov 9, 2022
6-K Current report (foreign issuer) Nov 2, 2022 Nov 2, 2022
6-K Current report (foreign issuer) Oct 21, 2022 Oct 21, 2022
6-K Current report (foreign issuer) Sep 28, 2022 Sep 28, 2022
EFFECT Filing Sep 13, 2022 —
6-K Current report (foreign issuer) Sep 8, 2022 Sep 8, 2022
POS AM Filing Sep 6, 2022 —
6-K Current report (foreign issuer) Sep 1, 2022 Sep 1, 2022
6-K Current report (foreign issuer) Aug 30, 2022 Aug 30, 2022
6-K Current report (foreign issuer) Aug 25, 2022 Aug 25, 2022
6-K Current report (foreign issuer) Aug 22, 2022 Aug 22, 2022
6-K Current report (foreign issuer) Jul 18, 2022 Jul 18, 2022
6-K Current report (foreign issuer) Jul 5, 2022 Jul 5, 2022
6-K Current report (foreign issuer) Jun 22, 2022 Jun 22, 2022
6-K Current report (foreign issuer) Jun 16, 2022 Jun 16, 2022
6-K Current report (foreign issuer) Jun 8, 2022 Jun 8, 2022
6-K Current report (foreign issuer) Jun 7, 2022 Jun 7, 2022
424B3 Prospectus May 26, 2022 —
6-K Current report (foreign issuer) May 26, 2022 May 26, 2022
6-K Current report (foreign issuer) May 23, 2022 May 23, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
DRTS (Nasdaq), DRTSW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Jerusalem, Israel
SEC filer status
Accelerated filer, Emerging growth company
SEC CIK
1871321

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.